Sign In
Buy PIK
$2.38
+0 (+0%)
At Close: Apr 15, 2025
Promising initial efficacy data with 60% volumetric response rate across doses and 29%* at the lowest tested dose of 100mg twice daily (BID) with all patients ongoing
Private Credit: Trying To Count The Cockroaches
10:30am, Monday, 11'th May 2026
In October 2025, JPMorgan Chase CEO Jamie Dimon issued a blunt warning after two high-profile private credit defaults — an auto parts manufacturer and a subprime auto lender — rattled the shadow b
SAN FRANCISCO, May 5, 2026 /PRNewswire/ -- Hercules Capital (NYSE: HTGC) faces a securities class action lawsuit which seeks to represent investors who purchased or otherwise acquired Hercules securi
SAN FRANCISCO, May 01, 2026 (GLOBE NEWSWIRE) -- Hercules Capital (NYSE: HTGC) faces a securities class action lawsuit which seeks to represent investors who purchased or otherwise acquired Hercules se
San Francisco, California--(Newsfile Corp. - April 29, 2026) - Hercules Capital (NYSE: HTGC) faces a securities class action lawsuit which seeks to represent investors who purchased or otherwise acqui
SAN FRANCISCO, April 27, 2026 /PRNewswire/ -- Hercules Capital (NYSE: HTGC) faces a securities class action lawsuit which seeks to represent investors who purchased or otherwise acquired Hercules sec
SAN FRANCISCO, April 22, 2026 (GLOBE NEWSWIRE) -- Hercules Capital (NYSE: HTGC) faces a securities class action lawsuit which seeks to represent investors who purchased or otherwise acquired Hercules
SAN FRANCISCO, April 17, 2026 /PRNewswire/ -- Hercules Capital (NYSE: HTGC) faces a securities class action lawsuit which seeks to represent investors who purchased or otherwise acquired Hercules secu
SAN FRANCISCO, April 14, 2026 (GLOBE NEWSWIRE) -- Hercules Capital (NYSE: HTGC) faces a securities class action lawsuit which seeks to represent investors who purchased or otherwise acquired Hercules
SAN FRANCISCO, April 7, 2026 /PRNewswire/ -- Hercules Capital (NYSE: HTGC) faces a securities class action lawsuit which seeks to represent investors who purchased or otherwise acquired Hercules secur
SAN FRANCISCO, April 3, 2026 /PRNewswire/ -- Hercules Capital (NYSE: HTGC) faces a securities class action lawsuit which seeks to represent investors who purchased or otherwise acquired Hercules secu
SAN FRANCISCO, April 1, 2026 /PRNewswire/ -- Hercules Capital (NYSE: HTGC) faces a securities class action lawsuit which seeks to represent investors who purchased or otherwise acquired Hercules secur
Designation supported by robust clinical data from ReDiscover trial with 600mg BID fasted and 400mg BID fed doses of zovegalisib in combination with fulvestrant Initial Phase 1/2 data of zovegalisib
MINNEAPOLIS, Oct. 18, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced detailed ef
MALMÖ, Sweden, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Oatly Group AB (Nasdaq: OTLY) (“Oatly” or the “Company”) announced today that it has issued SEK denominated senior secured floating rate bond
